Clinical Trial Update: Phase II Trial of Tarceva in Patients With Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

This document provides an update on a Phase II trial of Tarceva (erlotinib) in non-small cell lung cancer, with the current status of the trial listed as unknow…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Tarceva (erlotinib)

Snippet

Sponsor: Grupo Gallego de Cancer de Pulmon | Conditions: Non-Small Cell Lung Cancer | Phase 2 | Status: UNKNOWN